Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4793978
Max Phase: Preclinical
Molecular Formula: C51H100N24O11
Molecular Weight: 1225.52
Molecule Type: Unknown
Associated Items:
ID: ALA4793978
Max Phase: Preclinical
Molecular Formula: C51H100N24O11
Molecular Weight: 1225.52
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@@H](C)O
Standard InChI: InChI=1S/C51H100N24O11/c1-6-27(2)37(74-45(84)35(19-13-25-65-50(59)60)69-40(79)28(3)67-41(80)31(68-30(5)77)17-11-23-63-48(55)56)47(86)73-34(18-12-24-64-49(57)58)44(83)71-32(15-7-9-21-52)42(81)70-33(16-8-10-22-53)43(82)72-36(20-14-26-66-51(61)62)46(85)75-38(29(4)76)39(54)78/h27-29,31-38,76H,6-26,52-53H2,1-5H3,(H2,54,78)(H,67,80)(H,68,77)(H,69,79)(H,70,81)(H,71,83)(H,72,82)(H,73,86)(H,74,84)(H,75,85)(H4,55,56,63)(H4,57,58,64)(H4,59,60,65)(H4,61,62,66)/t27-,28-,29+,31-,32-,33-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: FCDZHZRHZBICBQ-NGBPWGJFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1225.52 | Molecular Weight (Monoisotopic): 1224.8003 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lewandowska-Goch MA,Kwiatkowska A,Łepek T,Ly K,Navals P,Gagnon H,Dory YL,Prahl A,Day R. (2021) Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin., 12 (3): [PMID:33738063] [10.1021/acsmedchemlett.0c00386] |
Source(1):